Paradise

Disneyland Resort Celebrates Disney100 with Grand Opening of Mickey & Minnie's Runaway Railway, New Nighttime Spectaculars, 'Magic Happens' Parade and More

Retrieved on: 
Friday, January 27, 2023
Walt Disney, Disneyland Hotel, Roger Rabbit's Car Toon Spin, Animation, Mickey & Minnie's Runaway Railway, River, Lunar New Year, Journey, Creativity, Music, House, Walt Disney Studios Park, Life, Drink, Walt Disney Imagineering, Dance, Water, Sleeping Beauty Castle, Feld Entertainment, Optimism, Paradise, Disney California Adventure Food & Wine Festival, Disneyland Resort, MagicBands, Hotel, The Disney Gallery, Star Wars, Disney Legends, Wondrous Bughouse, Magic, Platinum, Villas, Lightning, Disney Live Entertainment, Heart, The Happiest Place in Town, Rabbit, Runaway Railway, Food, Avenger, Toontown, Disney California Adventure, Walt Disney Animation Studios, Main Street, History, Amusement park, Film industry, Fireworks, The Walt Disney Company, Pixar, Mickey

Disney100 celebrates Disney storytellers, creators and fans around the world who, together, spark the magic and wonder of Disney.

Key Points: 
  • Disney100 celebrates Disney storytellers, creators and fans around the world who, together, spark the magic and wonder of Disney.
  • Disneyland Resort cast members will be among the first to experience select offerings with special #DisneyCastLife opportunities.
  • "We are excited to bring this milestone celebration to life right here at The Happiest Place on Earth," said Disneyland Resort President Ken Potrock.
  • Alongside the Disney100 anniversary celebration, the Hotels of the Disneyland Resort will debut new developments later this year.

Chinese Ink Art Reinvigorated Through Experimentation By Artist Liu Kuo-Sung

Retrieved on: 
Thursday, January 12, 2023
Water, Reading, Painting, University, No Great Mischief, Education, Architecture, Apollo, Permanent, Siong Leng Musical Association, Learning, National Gallery Singapore, Chinese, Paper, Curriculum, Moonwalk, Philosophy, Family, Lake, National Gallery, Collection, Travel, Beauty, Apollo 11, The Mongol in Our Midst, Exhibition, Research, Fifth Moon Group, Paradise, Gallery, Chinese University of Hong Kong, Movement, Nature, Film, Pottery, Book, Management, Liu, Ink

Liu Kuo-sung is a world-renowned modern ink master who reconstructed traditions with modernity to create unique ink paintings and transformed the art practice.

Key Points: 
  • Liu Kuo-sung is a world-renowned modern ink master who reconstructed traditions with modernity to create unique ink paintings and transformed the art practice.
  • Through his career, the 91-year-old artist has devoted his energies to exploring and advocating for the modernisation of Chinese painting.
  • Liu Kuo-sung at Liu Kuo-sung: Experimentation as Method, National Gallery Singapore 2022.
  • Liu's donation expands and elevates the Gallery's collection of ink paintings, which includes works by Singaporean ink artists, as well as Chinese ink master Wu Guanzhong.

ReCor Medical Names Lara Barghout President and Chief Executive Officer

Retrieved on: 
Tuesday, January 3, 2023
Biotechnology, Medical Devices, Health, Health Technology, Cardiology, Clinical trial, System, Siemens Healthineers, Risk, CE, Acquisition, Patient, Cardiovascular disease, Ministry of Education (Malaysia), Physician, Hypertension, Ōtsuka, Blood pressure, Senior, Paradise, Pharmaceutical industry, Management, ReCore

ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the appointment of Lara Barghout as President and Chief Executive Officer of ReCor.

Key Points: 
  • ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the appointment of Lara Barghout as President and Chief Executive Officer of ReCor.
  • Ms. Barghout brings more than 20 years of experience leading global businesses in the medical device industry.
  • “I am honored to lead the extraordinary team at ReCor at an exciting time in the company’s growth,” said Ms. Barghout.
  • “We are delighted to name Ms. Barghout President and CEO of ReCor.

ATLANTIS PARADISE ISLAND ANNOUNCES NASSAU PARADISE ISLAND WINE & FOOD FESTIVAL

Retrieved on: 
Tuesday, January 3, 2023
Cream, Ice cream, Atlantis Casino Resort Spa, Nancy Drew: Treasure in the Royal Tower, Mammal, Mackenzie, Animal, Sun, DJ, Paradise Food Court (Secunderabad), Restaurant, Atlantis, Cocktail, AKA, Cove, Michelin, Culture, Champagne, Abraj Al Bait, The Reef, Taste, The Coral, Heart, Martinique, Tennis, Multimedia, Food, Collection, Sale, Shark, Royal, J. J. Johnson, Education, Netflix, The Cove, ABPF, Festival, Rocco's Dinner Party, Sunset, Coral Reefs, Paradise, Bimini Road, Hotel, Baking, Spice, Tourism, Atlantis Resorts, Atlantis Paradise Island

PARADISE ISLAND, Bahamas, Jan. 3, 2023 /PRNewswire/ -- Atlantis Paradise Island, the Caribbean's most iconic destination resort in the Bahamas, is thrilled to announce its inaugural Nassau Paradise Island Wine & Food Festival (NPIWFF), taking place Wednesday, March 15 – Sunday, March 19, 2023. Tickets for the Nassau Paradise Island Wine & Food Festival are on sale now at npiwff.org.

Key Points: 
  • PARADISE ISLAND, Bahamas, Jan. 3, 2023 /PRNewswire/ -- Atlantis Paradise Island , the Caribbean's most iconic destination resort in the Bahamas, is thrilled to announce its inaugural Nassau Paradise Island Wine & Food Festival (NPIWFF), taking place Wednesday, March 15 – Sunday, March 19, 2023.
  • Tickets for the Nassau Paradise Island Wine & Food Festival are on sale now at npiwff.org .
  • After Atlantis' successful Taste of Paradise Food & Wine Festival, the newly named Nassau Paradise Island Wine & Food Festival will be expanded to include local and regional chefs and restaurants, music performances, exclusive dinners, beachside parties, culinary demos and family-friendly activities hosted throughout the resort.
  • Atlantis Paradise Island , a lush, oceanside resort located on Paradise Island in the Bahamas, is a dynamic destination celebrating its 25th anniversary with bold multimillion-dollar renovations, exciting new partnerships, and reimagined guest experiences.

Thought-Provoking Historical Fiction Portrays the Life and Struggles of Women in Medieval Times

Retrieved on: 
Wednesday, December 28, 2022
Paradise, Game of Thrones, Rogers, Hundred Years' War, Love, History, Beauty, Holy Roman Emperor, Life, Woman, Frederick II, Holy Roman Emperor, Intelligence, Entertainment, Purgatory

BOSTON, Dec. 28, 2022 /PRNewswire/ -- Author Amelia Rogers' novel, "Four Princesses from Provence," highlights the importance of women's roles in history.

Key Points: 
  • BOSTON, Dec. 28, 2022 /PRNewswire/ -- Author Amelia Rogers' novel, "Four Princesses from Provence," highlights the importance of women's roles in history.
  • This novel tells the tale of the four daughters of the Count of Provence.
  • One sister discovers that her new life is a whole different world from the one she knew, and it's going to change everything she believes and knows.
  • Most of all, she hopes that they think about the underappreciated but crucial role that women played in shaping these events.

Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration

Retrieved on: 
Wednesday, November 30, 2022
Health, FDA, Medical Devices, Technology, Neurology, Clinical Trials, Hardware, Hypertension, Paradise, Food, Renal artery, ReCore, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, System, PMA, SOLO, Blood pressure, Medical device, FDA, Pharmaceutical industry

Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) and ReCor Medical, Inc. (ReCor, subsidiary of Otsuka Medical Devices) announced the filing of the pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the Paradise uRDN System in the treatment of uncontrolled hypertension.

Key Points: 
  • Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) and ReCor Medical, Inc. (ReCor, subsidiary of Otsuka Medical Devices) announced the filing of the pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the Paradise uRDN System in the treatment of uncontrolled hypertension.
  • Paradise uRDN uses a combination of ultrasound energy to denervate the renal nerves and a water-filled balloon to protect the renal artery.
  • Since 2009, ReCor has been focused on developing and testing the Paradise uRDN System to treat hypertension safely and effectively.
  • In September of this year, ReCor and Otsuka Medical Devices announced that the trial successfully reached its primary efficacy endpoint.

ReCor Medical and Otsuka Medical Devices Announce Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration

Retrieved on: 
Wednesday, November 30, 2022
Medical Devices, FDA, Health, Health Technology, Cardiology, Biotechnology, Hypertension, Paradise, Food, Renal artery, ReCore, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, System, PMA, SOLO, Blood pressure, FDA, Pharmaceutical industry

ReCor Medical, Inc. (ReCor) and its parent company, Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) today announced the filing of the pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the Paradise uRDN System in the treatment of uncontrolled hypertension.

Key Points: 
  • ReCor Medical, Inc. (ReCor) and its parent company, Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) today announced the filing of the pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the Paradise uRDN System in the treatment of uncontrolled hypertension.
  • Paradise uRDN uses a combination of ultrasound energy to denervate the renal nerves and a water-filled balloon to protect the renal artery.
  • Since 2009, ReCor has been focused on developing and testing the Paradise uRDN System to treat hypertension safely and effectively.
  • ReCor has pioneered the use of the Paradise Ultrasound Renal Denervation (uRDN) System for the treatment of hypertension.

All New Hurricane Hole Superyacht Marina Celebrates Grand Opening in The Bahamas

Retrieved on: 
Tuesday, November 29, 2022
Wi-Fi, Internet, Waste management, Pharmacy, Paradise, Restaurant, Tourism, Wine, Amusement park, Hotel

PARADISE ISLAND, The Bahamas, Nov. 29, 2022 /PRNewswire/ -- The new Hurricane Hole Superyacht Marina recently celebrated its grand opening after a significant redesign that completely renovated and expanded the premier deep-water marina of The Bahamas.

Key Points: 
  • PARADISE ISLAND, The Bahamas, Nov. 29, 2022 /PRNewswire/ -- The new Hurricane Hole Superyacht Marina recently celebrated its grand opening after a significant redesign that completely renovated and expanded the premier deep-water marina of The Bahamas.
  • Honourable Philip Davis, Prime Minister of The Bahamas, officially opened the marina after its world-class redesign.
  • The Hurricane Hole Superyacht Marina and the Residences at Paradise Landing are fitting and welcome additions to the continued development of The Bahamas' world-renowned tourism product," Davis said.
  • To learn more about purchasing or renting a slip at the premier superyacht marina, visit Hurricane Hole or call 242-603-1950.

Phoenix Nursing Home Received Critical ERC Benefits With Help From Innovation Refunds

Retrieved on: 
Monday, September 26, 2022
Cranmer, Caregiver, Parent, GLOBE, Time, Radio, ERC, COVID-19, Partnership, Paradise, COVID, Government, Online shopping

As a turnkey tax solutions firm specializing in Employee Retention Credit (ERC) and payroll tax refunds, Innovation Refunds took care of the entire ERC application process and was able to connect Paradise for Parents with the capital they needed to maintain operations.

Key Points: 
  • As a turnkey tax solutions firm specializing in Employee Retention Credit (ERC) and payroll tax refunds, Innovation Refunds took care of the entire ERC application process and was able to connect Paradise for Parents with the capital they needed to maintain operations.
  • When Hal Cranmer, co-owner of Paradise for Parents, first heard about Innovation Refunds through a radio advertisement, he knew he needed to take immediate action.
  • The spread of the virus severely impacted the U.S. supply chain, and the nursing home needed capital to cover the costs of critical supplies for residents.
  • The Innovation Refunds team oversaw and managed the entire ERC application process for Paradise for Parents.

Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

Retrieved on: 
Tuesday, September 20, 2022
Education, Medical Devices, Health, FDA, Clinical Trials, University, Columbia University Vagelos College of Physicians and Surgeons, Trial of the century, FDA, Columbia University, Mercury (element), Hospital, Hypertension, BP, Patient, Medical device, Physician, Surgeon, Paradise, TCT, Pharmaceutical industry, MD, Medicine

Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) a wholly owned subsidiary of Otsuka Holdings today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension.

Key Points: 
  • Otsuka Medical Devices Co., Ltd. (Otsuka Medical Devices) a wholly owned subsidiary of Otsuka Holdings today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension.
  • Principal Investigator Ajay J. Kirtane, MD, Professor of Medicine at Columbia University, Vagelos College of Physicians and Surgeons / NewYork-Presbyterian Hospital, presented the study results in a Late Breaking Clinical Science session at the TCT 2022 Annual Meeting.
  • Conducted as an international, multicenter study, RADIANCE II is a US FDA IDE, randomized, sham-controlled pivotal trial of the Paradise uRDN System in the treatment of patients with uncontrolled hypertension.
  • Patients were to remain off antihypertensive medications throughout the 2 months of follow-up unless specified BP criteria were exceeded.